Sağlık Teknolojisi
Arjantin Şirketleri tek bir sektörde faaliyet göstermektedir:sağlık teknolojisi
Bu Arjantin Şirketleri aynı sektörde, sağlık teknolojisi, faaliyet göstermektedir. En fazla ayrıntıyı almanıza yardımcı olmak için fiyat, değişim ve diğer istatistiklerle donatılmıştır. Liste her stratejiye uygun hisse senetleri içerir: ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 gibi büyük sermayeli devler, ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD) gibi en çok kazananlar ve daha fazlası. Listeyi filtreleyin ve şirketlerin performansını uygun bir şekilde kontrol edin.
Sembol | Piyasa Değeri | Fiyat | Değişim % | Hacim | Bağ Hacim | FKO | EPS Seyreltilmiş TTM | EPS Seyreltilmiş Büyüme TTM YY | Tmt getirisi % TTM | Analist Değerlendirmesi |
|---|---|---|---|---|---|---|---|---|---|---|
 LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1DR | 609.612 T ARS | 14229.000 ARS | +1.67% | 970 | 0.63 | — | — | — | — | — |
| LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD) DR | 609.612 T ARS | 14.000 USD | +6.06% | 42 | 0.47 | — | — | — | — | — |
 JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHSDR | 307.837 T ARS | 10584.000 ARS | +0.03% | 9.34 K | 0.74 | 43.57 | 242.90 ARS | +459.57% | 0.86% | — |
| DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 307.837 T ARS | 1153.000 ARS | 0.00% | 1 | 0.00 | — | — | — | — | — |
| JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD) DR | 307.837 T ARS | 10.350 USD | +0.49% | 577 | 1.00 | 36.48 | 242.90 ARS | +48.88% | 0.86% | — |
 MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50)DR | 290.457 T ARS | 28471.000 ARS | +0.42% | 230 | 0.08 | — | — | — | — | — |
| MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD) DR | 290.457 T ARS | 28.850 USD | +4.91% | 1 | 0.11 | — | — | — | — | — |
 ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COMDR | 247.055 T ARS | 17254.500 ARS | −4.47% | 1.429 K | 0.36 | 21.49 | 802.79 ARS | −6.12% | 1.02% | — |
| ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD) DR | 247.055 T ARS | 17.550 USD | +0.29% | 17 | 0.19 | 17.67 | 802.79 ARS | −77.92% | 1.02% | — |
 AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25DR | 203.224 T ARS | 40911.000 ARS | +0.85% | 1.121 K | 1.04 | 103.21 | 396.38 ARS | +306.81% | 1.04% | — |
| AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD) DR | 203.224 T ARS | 38.000 USD | −3.43% | 1 | 0.15 | 82.08 | 396.38 ARS | +8.24% | 1.04% | — |
 TMOTHERMO FISHER SCIENTIFIC INC CEDEAR EACH 22 REP 1DR | 191.391 T ARS | 28327.500 ARS | +2.82% | 50 | 0.33 | — | — | — | — | — |
 NVSNOVARTIS AG CEDEAR EACH 4 REP 1DR | 169.69 T ARS | 26495.500 ARS | −1.47% | 13 | 0.16 | — | — | — | — | — |
| NVSDNOVARTIS AG CEDEAR EAC 4 REP 1(USD) DR | 169.69 T ARS | 24.250 USD | +4.98% | 2 | 0.34 | — | — | — | — | — |
 ABTABBOTT LABORATORIES CEDEAR EACH 4 REP 1DR | 163.098 T ARS | 29249.000 ARS | +1.50% | 320 | 0.43 | 82.26 | 355.57 ARS | +193.15% | 0.53% | — |
| ABTDABBOTT LABORATORIES CEDEAR EAC 4 REP 1(USD) DR | 163.098 T ARS | 27.900 USD | 0.00% | 8 | 1.27 | 67.18 | 355.57 ARS | −22.00% | 0.53% | — |
 AMGNAMGEN INC CEDEAR EACH 30 REP 1DR | 126.475 T ARS | 9775.000 ARS | +0.91% | 1.357 K | 0.18 | — | — | — | — | — |
| AMGNDAMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD) DR | 126.475 T ARS | 9.800 USD | +2.08% | 5 | 0.09 | — | — | — | — | — |
 PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05DR | 125.374 T ARS | 6902.500 ARS | +0.73% | 7.765 K | 0.33 | — | — | — | — | — |
| PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD) DR | 125.374 T ARS | 6.710 USD | +0.15% | 347 | 0.39 | — | — | — | — | — |
 MDTMEDTRONIC PLC CEDEAR EACH 4 REP 1DR | 92.553 T ARS | 21595.000 ARS | +0.69% | 42 | 0.26 | — | — | — | — | — |
 BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1DR | 79.472 T ARS | 16245.500 ARS | +0.40% | 1.302 K | 2.34 | — | — | — | — | — |
| BMYDBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 DR | 79.472 T ARS | 15.400 USD | −9.41% | 2 | 0.39 | — | — | — | — | — |
 GSKGSK PLC CEDEAR EACH REPR 1/4 ADRDR | 74.493 T ARS | 11201.000 ARS | +1.83% | 484 | 2.11 | 57.65 | 194.30 ARS | −31.41% | 1.32% | — |
| GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD) DR | 74.493 T ARS | 10.300 USD | +0.98% | 7 | 0.24 | 42.85 | 194.30 ARS | −83.87% | 1.32% | — |
 GILDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 COM USD0.001DR | 71.308 T ARS | 17771.500 ARS | +0.81% | 886 | 2.85 | — | — | — | — | — |
| GILDDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 SHS (USD) DR | 71.308 T ARS | 17.100 USD | −0.58% | 15 | 1.38 | — | — | — | — | — |
 BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005DR | 26.587 T ARS | 17470.000 ARS | +3.76% | 1.006 K | 0.72 | — | — | — | — | — |
| BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD) DR | 26.587 T ARS | 16.250 USD | −18.75% | 20 | 2.47 | — | — | — | — | — |
 PHGKONINKLIJKE PHILIPS NV CEDEAR EACH REPR 1/5 ADRDR | 16.827 T ARS | 4580.000 ARS | +2.64% | 838 | 1.20 | — | — | — | — | — |
 RICHLABORATORIOS RICHMOND SACIF | 70.981 B ARS | 879.000 ARS | +1.91% | 2.657 K | 0.56 | — | −130.78 ARS | — | 0.00% | — |
 ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 3.896 B ARS | 91.500 ARS | 0.00% | 250 | 0.06 | — | — | — | 0.00% | — |